BACKGROUND: Nijmegen breakage syndrome (NBS) is an autosomal recessive chromosomal instability disorder with hypersensitivity to ionising radiation. The clinical phenotype is characterised by congenital microcephaly, mild dysmorphic facial appearance, growth retardation, immunodeficiency, and greatly increased risk for lymphoreticular malignancy. Most NBS patients are of Slavic origin and homozygous for the founder mutation 657del5. The frequency of 657del5 heterozygotes in the Czech population is 1:150. Recently, another NBS1 mutation, 643C>T(R215W), with uncertain pathogenicity was found to have higher frequency among tumour patients of Slavic origin than in controls. This alteration results in the substitution of the basic amino acid arginine with the non-polar tryptophan and thus could potentially interfere with the function of the NBS1 protein, nibrin. METHODS AND RESULTS: Children with congenital microcephaly are routinely tested for the 657del5 mutation in the Czech and Slovak Republics. Here, we describe for the first time a severe form of NBS without chromosomal instability in monozygotic twin brothers with profound congenital microcephaly and developmental delay who are compound heterozygotes for the 657del5 and 643C>T(R215W) NBS1 mutations. Both children showed reduced expression of full length nibrin when compared with a control and a heterozygote for the 657del5 mutation. Radiation response processes such as phosphorylation of ATM and phosphorylation/stabilisation of p53, which are promoted by NBS1, are strongly reduced in cells from these patients. CONCLUSIONS: Interestingly, the patients are more severely affected than classical NBS patients. Consequently, we postulate that homozygosity for the 643C>T(R215W) mutation will also lead to a, possibly very, severe disease phenotype.

Department of Clinical Genetics Institute of Biology and Medical Genetics 2nd Medical School of Charles University Prague Czech Republic

Zobrazit více v PubMed

Weemaes C M, Hustinx T W, Scheres J M, van Munster P J, Bakkeren J A, Taalman R D. A new chromosomal instability disorder: the Nijmegen breakage syndrome. Acta Paediatr Scand 198170557–564. PubMed

The International Nijmegen Breakage Syndrome Study Group Nijmegen breakage syndrome. Arch Dis Child 200082400–406. PubMed PMC

Varon R, Seemanova E, Chrzanowska K, Hnateyko O, Piekutowska‐Abramczuk D, Krajewska‐Walasek M, Sykut‐Cegielska J, Sperling K, Reis A. Clinical ascertainment of Nijmegen breakage syndrome (NBS) and prevalence of the major mutation, 657del5, in three Slav populations. Eur J Hum Genet 20008900–902. PubMed

Varon R, Vissinga C, Platzer M, Cerosaletti K M, Chrzanowska K H, Saar K, Beckmann G, Seemanova E, Cooper P R, Nowak N J, Stumm M, Weemaes C M, Gatti R A, Wilson R K, Digweed M, Rosenthal A, Sperling K, Concannon P, Reis A. Nibrin, a novel DNA double‐strand break repair protein, is mutated in Nijmegen breakage syndrome. Cell 199893467–476. PubMed

Seeman P, Gebertova K, Paderova K, Sperling K, Seemanova E. Nijmegen breakage syndrome in 13% of age‐matched Czech children with primary microcephaly. Pediatr Neurol 200430195–200. PubMed

Seemanova E, Pohanka V, Seeman P, Misovicova N, Behunova J, Kvasnicova M, Dlholucky S, Valachova A, Cisarik F, Veghova E, Varon R, Sperling K. [Nijmegen breakage syndrome in Slovakia]. Cas Lek Cesk 2004143538–41 discussion, 542. PubMed

Varon R, Reis A, Henze G, von Einsiedel H G, Sperling K, Seeger K. Mutations in the Nijmegen Breakage Syndrome gene (NBS1) in childhood acute lymphoblastic leukemia (ALL). Cancer Res 2001613570–3572. PubMed

Taylor G M, O'Brien H P, Greaves M F, Ravetto P F, Eden O B. Correspondence re: R. Varon et al., Mutations in the Nijmegen breakage syndrome gene (NBS1) in childhood acute lymphoblastic leukemia. Cancer Res. 61: 3570–3572, 2001, Cancer Res. 2003;63: 6563–4; author reply 6565 PubMed

Steffen J, Varon R, Mosor M, Maneva G, Maurer M, Stumm M, Nowakowska D, Rubach M, Kosakowska E, Ruka W, Nowecki Z, Rutkowski P, Demkow T, Sadowska M, Bidzinski M, Gawrychowski K, Sperling K. Increased cancer risk of heterozygotes with NBS1 germline mutations in Poland. Int J Cancer 200411167–71. PubMed

Schrock E, Veldman T, Padilla‐Nash H, Ning Y, Spurbeck J, Jalal S, Shaffer L G, Papenhausen P, Kozma C, Phelan M C, Kjeldsen E, Schonberg S A, O'Brien P, Biesecker L, du Manoir S, Ried T. Spectral karyotyping refines cytogenetic diagnostics of constitutional chromosomal abnormalities. Hum Genet 1997101255–262. PubMed

Antoccia A, Stumm M, Saar K, Ricordy R, Maraschio P, Tanzarella C. Impaired p53‐mediated DNA damage response, cell‐cycle disturbance and chromosome aberrations in Nijmegen breakage syndrome lymphoblastoid cell lines. Int J Radiat Biol 199975583–591. PubMed

Gatei M, Young D, Cerosaletti K M, Desai‐Mehta A, Spring K, Kozlov S, Lavin M F, Gatti R A, Concannon P, Khanna K. ATM‐dependent phosphorylation of nibrin in response to radiation exposure. Nat Genet 200025115–119. PubMed

Maser R S, Zinkel R, Petrini J H. An alternative mode of translation permits production of a variant NBS1 protein from the common Nijmegen breakage syndrome allele. Nat Genet 200127417–421. PubMed

Tanzanella C, Antoccia A, Spadoni E, di Masi A, Pecile V, Demori E, Varon R, Marseglia G L, Tiepolo L, Maraschio P. Chromosome instability and nibrin protein variants in NBS heterozygotes. Eur J Hum Genet 200311297–303. PubMed

Zhu J, Petersen S, Tessarollo L, Nussenzweig A. Targeted disruption of the Nijmegen breakage syndrome gene NBS1 leads to early embryonic lethality in mice. Curr Biol 200111105–109. PubMed

Dumon‐Jones V, Frappart P O, Tong W M, Sajithlal G, Hulla W, Schmid G, Herceg Z, Digweed M, Wang Z Q. Nbn heterozygosity renders mice susceptible to tumor formation and ionizing radiation‐induced tumorigenesis. Cancer Res 2003637263–7269. PubMed

Demuth I, Frappart P O, Hildebrand G, Melchers A, Lobitz S, Stockl L, Varon R, Herceg Z, Sperling K, Wang Z Q, Digweed M. An inducible null mutant murine model of Nijmegen breakage syndrome proves the essential function of NBS1 in chromosomal stability and cell viability. Hum Mol Genet 2004132385–2397. PubMed

Gatti R A, Tward A, Concannon P. Cancer risk in ATM heterozygotes: a model of phenotypic and mechanistic differences between missense and truncating mutations. Mol Genet Metab 199968419–423. PubMed

Uziel T, Lerenthal Y, Moyal L, Andegeko Y, Mittelman L, Shiloh Y. Requirement of the MRN complex for ATM activation by DNA damage. EMBO J 2003225612–5621. PubMed PMC

Lee J H, Paull T T. Direct activation of the ATM protein kinase by the Mre11/Rad50/Nbs1 complex. Science 200430493–96. PubMed

Kitagawa R, Bakkenist C J, McKinnon P J, Kastan M B. Phosphorylation of SMC1 is a critical downstream event in the ATM‐NBS1‐BRCA1 pathway. Genes Dev 2004181423–1438. PubMed PMC

Buscemi G, Savio C, Zannini L, Micciche F, Masnada D, Nakanishi M, Tauchi H, Komatsu K, Mizutani S, Khanna K, Chen P, Concannon P, Chessa L, Delia D. Chk2 activation dependence on Nbs1 after DNA damage. Mol Cell Biol 2001215214–5222. PubMed PMC

Girard P M, Riballo E, Begg A C, Waugh A, Jeggo P A. Nbs1 promotes ATM dependent phosphorylation events including those required for G1/S arrest. Oncogene 2002214191–4199. PubMed

Frappart P O, Tong W M, Demuth I, Radovanovic I, Herceg Z, Aguzzi A, Digweed M, Wang Z Q. An essential function for NBS1 in the prevention of ataxia and cerebellar defects. Nat Med 200511538–544. PubMed

Bekiesinska‐Figatowska M, Chrzanowska K H, Sikorska J, Walecki J, Krajewska‐Walasek M, Jozwiak S, Kleijer W J. Cranial MRI in the Nijmegen breakage syndrome. Neuroradiology 20004243–47. PubMed

Chrzanowska K H, Stumm M, Bekiesiska‐Figatowska M, Varon R, Biaecka M, Gregorek H, Michakiewicz J, Krajewska‐Walasek M, Jowiak S, Reis A. Atypical clinical picture of the Nijmegen breakage syndrome associated with developmental abnormalities of the brain. J Med Genet 200138E3 PubMed PMC

Nakanishi K, Taniguchi T, Ranganathan V, New H V, Moreau L A, Stotsky M, Mathew C G, Kastan M B, Weaver D T, D'Andrea A D. Interaction of FANCD2 and NBS1 in the DNA damage response. Nat Cell Biol 20024913–920. PubMed

Gennery A R, Slatter M A, Bhattacharya A, Barge D, Haigh S, O'Driscoll M, Coleman R, Abinun M, Flood T J, Cant A J, Jeggo P A. The clinical and biological overlap between Nijmegen Breakage Syndrome and Fanconi anemia. Clin Immunol 2004113214–219. PubMed

Resnick I B, Kondratenko I, Togoev O, Vasserman N, Shagina I, Evgrafov O, Tverskaya S, Cerosaletti K M, Gatti R A, Concannon P. Nijmegen breakage syndrome: clinical characteristics and mutation analysis in eight unrelated Russian families. J Pediatr 2002140355–361. PubMed

Seemanová E, Koutecky J, Radvanská J, Starý J, Seeman P, Gebertová K, Varon R, Sperling K. Nositelé mutací NBS1 genu mezi pacienty detské onkologie. Csl Pediat 200459242–245.

Consensus Recommendations for the Clinical Management of Hematological Malignancies in Patients with DNA Double Stranded Break Disorders